- Home
- SIGI vs AXSM Comparison
SIGI vs AXSM Comparison
Compare SIGI & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGI
- AXSM
- Stock Information
- Founded
- SIGI 1926
- AXSM 2012
- Country
- SIGI United States
- AXSM United States
- Employees
- SIGI N/A
- AXSM N/A
- Industry
- SIGI Property-Casualty Insurers
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- SIGI Finance
- AXSM Health Care
- Exchange
- SIGI Nasdaq
- AXSM Nasdaq
- Market Cap
- SIGI 5.1B
- AXSM 5.1B
- IPO Year
- SIGI N/A
- AXSM 2015
- Fundamental
- Price
- SIGI $86.28
- AXSM $105.07
- Analyst Decision
- SIGI Hold
- AXSM Strong Buy
- Analyst Count
- SIGI 8
- AXSM 15
- Target Price
- SIGI $94.00
- AXSM $170.20
- AVG Volume (30 Days)
- SIGI 342.7K
- AXSM 611.7K
- Earning Date
- SIGI 07-17-2025
- AXSM 05-05-2025
- Dividend Yield
- SIGI 1.76%
- AXSM N/A
- EPS Growth
- SIGI N/A
- AXSM N/A
- EPS
- SIGI 3.68
- AXSM N/A
- Revenue
- SIGI $4,981,891,000.00
- AXSM $432,157,000.00
- Revenue This Year
- SIGI $6.05
- AXSM $63.30
- Revenue Next Year
- SIGI $7.43
- AXSM $61.15
- P/E Ratio
- SIGI $23.42
- AXSM N/A
- Revenue Growth
- SIGI 13.30
- AXSM 72.16
- 52 Week Low
- SIGI $78.13
- AXSM $64.11
- 52 Week High
- SIGI $103.56
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- SIGI 42.24
- AXSM 43.88
- Support Level
- SIGI $85.64
- AXSM $106.09
- Resistance Level
- SIGI $90.10
- AXSM $109.64
- Average True Range (ATR)
- SIGI 1.84
- AXSM 3.53
- MACD
- SIGI -0.31
- AXSM -0.29
- Stochastic Oscillator
- SIGI 21.00
- AXSM 14.29
About SIGI Selective Insurance Group Inc.
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. Since 1977, Selective has focused its sales efforts on small businesses, offering commercial products that include workers' compensation, general liability, property, and auto insurance. Selective also has a small personal insurance segment (under 20% of total premiums), selling auto and homeowner's coverage.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.